Related Experiment Video
Updated: Apr 20, 2026

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities
1Department of Dermatology, Baylor University Medical Center Dallas, 3900 Junius Street, Suite 145, Dallas, TX 75246, USA.
Insights
Patients with moderate to severe psoriasis face higher risks of cardiovascular disease, obesity, and diabetes. Managing psoriasis inflammation may reduce these risks, though more research is needed.
Area of Science:
- Dermatology
- Cardiology
- Endocrinology
Background:
- Psoriasis is linked to increased risks of cardiovascular disease, obesity, diabetes mellitus, and metabolic syndrome.
- Inflammatory pathways are implicated in the comorbidities associated with psoriasis.
- Current understanding of the precise mechanisms linking psoriasis and cardiovascular disease requires further definition.
Purpose of the Study:
- To review current literature on cardiovascular and metabolic comorbidities in psoriasis.
- To identify existing research gaps in this field.
- To propose management strategies for reducing cardiovascular risk in psoriasis patients.
Main Methods:
- Literature review of studies on psoriasis and its associated cardiovascular and metabolic conditions.
- Analysis of inflammatory pathways common to psoriasis and cardiovascular disease.
- Synthesis of current evidence to inform management strategies.
Main Results:
- Patients with moderate to severe psoriasis exhibit elevated risks for cardiovascular disease, obesity, diabetes, and metabolic syndrome.
- Inflammatory processes are likely key mediators in the development of these comorbidities.
- Robust evidence supporting the reduction of cardiovascular inflammation via systemic psoriasis treatment is still limited.
Conclusions:
- Psoriasis is associated with significant cardiovascular and metabolic comorbidities.
- Further research is necessary to elucidate the underlying mechanisms and confirm the benefits of anti-inflammatory treatments on cardiovascular health.
- Proactive management of cardiovascular risk factors is crucial for patients with moderate to severe psoriasis.
Abstract:
There is evidence that patients with moderate to severe psoriasis have an increased risk of conditions such as cardiovascular disease, obesity, diabetes mellitus, and metabolic syndrome. The precise mechanisms underlying the observed increase in cardiovascular disease in psoriasis remain to be defined but inflammatory pathways mutual to both conditions are probably involved. Suppression of systemic inflammation in psoriasis could help reduce cardiovascular inflammation but robust evidence is still lacking evidence is lacking. This article summarizes the current literature on cardiovascular and metabolic comorbidities in psoriasis, identifies research gaps, and suggests management strategies to reduce cardiovascular risk in patients with moderate to severe psoriasis.
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease I: Introduction
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...

